REGISTERED
on 29 Oct 2024
Last Applicant/ Owned by
2380 Conejo Spectrum St, Suite 200
Thousand Oaks
CA
91320
Serial Number
90804919 filed on 30th Jun 2021
Registration Number
7552673 registered on 29th Oct 2024
Correspondent Address
David E. Heisey
Filing Basis
1. intent to use
2. use application currently
Disclaimer
NO DATA
ATARA BIO
House mark for pharmaceutical and therapeutic preparations for the treatment of patients with viral diseases, fungal diseases, and chronic diseases, namely, cancer, kidney disease, diabetes, cachexia, age related sarcopenia, and protein-energy wasting, none of the foregoing to be used for pharmaceutical preparations for treatment of rheumatoid arthritis and psoriasis
Classification Information
Class [005]
Pharmaceutical Products
House mark for pharmaceutical and therapeutic preparations for the treatment of patients with viral diseases, fungal diseases, and chronic diseases, namely, cancer, kidney disease, diabetes, cachexia, age related sarcopenia, and protein-energy wasting, none of the foregoing to be used for pharmaceutical preparations for treatment of rheumatoid arthritis and psoriasis
First Use Date in General
26th Oct 2017
First Use Date in Commerce
26th Oct 2017
Mark Details
Serial Number
No 90804919
Mark Type
No Service/Collective Mark
Attorney Docket Number
No 33PB-logoB&W
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Design Code(s)
24.11.02 -
Crowns open at the top
26.17.10 -
Zig-zag line(s)
Legal History
| Status Date | Action Taken |
|---|---|
| 29th Oct 2024 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
| 29th Oct 2024 | REGISTERED-PRINCIPAL REGISTER |
| 23rd Sep 2024 | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
| 23rd Sep 2024 | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED |
| 29th Aug 2024 | ASSIGNED TO EXAMINER |
| 09th Apr 2024 | STATEMENT OF USE PROCESSING COMPLETE |
| 06th Apr 2024 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| 18th Mar 2024 | USE AMENDMENT FILED |
| 18th Mar 2024 | TEAS STATEMENT OF USE RECEIVED |
| 20th Sep 2023 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |